Brain cancer is one of the most serious conditions seen in the field of medicine, which probably goes without saying. There are so many details to consider and each of them will be given focus when talking about how to help the aforementioned condition. Is it possible that a certain mechanism can come into play for this purpose? After reading a recent report, it seems as though this is the case and the specifics that have been outlined were, to say the least, intriguing.
Companies along the lines of Voices against Brain Cancer know all too well just how complicated this particular condition can be. Brain cancer is complex and the various cells and substances that are seen lend credence to the idea that certain drugs can come into effect, provided they are safe. In many cases, as an article on Medical Xpress detailed, therapies primarily focus on the progression of glioma, the most malignant type of cancer. The article also detailed how an FDA-approved food additive could come into play.
Medical Xpress said that the food additive in question was surveyed by University of Vermont professor Diane M. Jaworski, Ph.D., and former graduate student Patrick Long. They were able to focus onaspartoacylase, which is an enzyme that can break down a compound by the name of N-acetyl-L-aspartate. NAA is the brain's primary storage form of acetate, which is able to turn genes on or off. When it comes to the condition that is referred to as glioma, both the levels of NAA and expression of ASPA are decreased.
It seems as though there were various efforts done in order to help increase the levels of ASPA expressions but the article said that, unfortunately, proliferation resulted from it. However, the report made mention of a food additive to be utilized later on and it was called glyceryl triacetate. Not only would this potentially be able to help glioma patients but it has been implemented in order to assist patients with Canavan disease as well. This is an inherited condition that results in brain cell damage.
According to the article, GTA was put to use and the results that came to surface were rather positive. It showed lower levels of growth in terms of glioma stem cells but another positive to consider was that the healthy cells remained unharmed. This, to me, is the most important factor to consider about this condition. It shows that there is a level of potential to consider, especially when considering that toxicity and side-effects alike are practically nonexistent with GTA being put to use for research purposes.
Companies along the lines of Voices against Brain Cancer know all too well just how complicated this particular condition can be. Brain cancer is complex and the various cells and substances that are seen lend credence to the idea that certain drugs can come into effect, provided they are safe. In many cases, as an article on Medical Xpress detailed, therapies primarily focus on the progression of glioma, the most malignant type of cancer. The article also detailed how an FDA-approved food additive could come into play.
Medical Xpress said that the food additive in question was surveyed by University of Vermont professor Diane M. Jaworski, Ph.D., and former graduate student Patrick Long. They were able to focus onaspartoacylase, which is an enzyme that can break down a compound by the name of N-acetyl-L-aspartate. NAA is the brain's primary storage form of acetate, which is able to turn genes on or off. When it comes to the condition that is referred to as glioma, both the levels of NAA and expression of ASPA are decreased.
It seems as though there were various efforts done in order to help increase the levels of ASPA expressions but the article said that, unfortunately, proliferation resulted from it. However, the report made mention of a food additive to be utilized later on and it was called glyceryl triacetate. Not only would this potentially be able to help glioma patients but it has been implemented in order to assist patients with Canavan disease as well. This is an inherited condition that results in brain cell damage.
According to the article, GTA was put to use and the results that came to surface were rather positive. It showed lower levels of growth in terms of glioma stem cells but another positive to consider was that the healthy cells remained unharmed. This, to me, is the most important factor to consider about this condition. It shows that there is a level of potential to consider, especially when considering that toxicity and side-effects alike are practically nonexistent with GTA being put to use for research purposes.
About the Author:
For more details regarding brain cancer and how you can assist, go to Voices against Brain Cancer.
No comments:
Post a Comment